We studied phosphorylation of Smad2 after treatment with TGF-β of UCMD and control cells and although we detected phosphorylation of Smad2 we did not find significant differences between patients and control cells (data not shown). The gene discussed is TGFB1; the disease is Ullrich congenital muscular dystrophy.